Search

Search Constraints

You searched for: Author/Creator Capron, Claude

Search Results

1. 337 Pembrolizumab in combination with xelox bevacizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer and a high immune infiltrate: a proof of concept study. FFCD 1703 POCHI. (10th December 2020)

2. 337 Pembrolizumab in combination with xelox bevacizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer and a high immune infiltrate: a proof of concept study. FFCD 1703 POCHI. (9th November 2020)

3. A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the "Mono‐dysplasia‐score" combined with flow cytometric quantification of monocyte subsets. (24th October 2019)

5. Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild‐type and mutant forms of KIT. Issue 3 (30th October 2012)

6. FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. Issue 7 (July 2022)

7. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry. (18th June 2020)

8. Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma. (4th March 2019)

9. Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial. Issue 10 (October 2021)